We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Techniques for Analyzing Molecular Changes in Tissue

By HospiMedica staff writers
Posted on 04 Nov 2003
A study has shown that combining minimally invasive tissue sampling with ultra-sensitive cell analysis, or microgenomics, provides an easier and less-traumatic way to monitor a patient's responsiveness to drugs. More...
The results were presented at the annual meeting of the American Association of Cancer Research in Phoenix (AZ, USA).

Over time, doctors and researchers may require repeated tissue samples and analysis to monitor the effectiveness of drugs being developed to prevent the growth of breast cancer, for example. In the study, researchers analyzed fine needle aspiration (FNA) tissue samples from 13 high-risk women, using small-gauge needles similar to those used to obtain a blood sample. Then they carefully selected 100-500 of the most abnormal-appearing cells from the thousands of cells in the fine needle aspirate. The atypical cells were selected using laser capture microdissection (LCM), a proprietary approach developed by Arcturus (Mountain View, CA, USA) and the US National Institutes of Health.

With the precision of laser capture, the researchers performed subsequent cell analysis on a population of atypical cells, rather than on the whole specimen. LCM avoids analyzing a mixture of healthy and precancerous cells found in breast cancer, which can distort test results. The FNA samples were preserved in formalin to prevent degradation of the tissue. New extraction techniques developed by Arcturus reverse the cross-linking process caused by the formalin and allow extraction and purification of messenger RNA (mRNA) from the samples, used to measure the expression levels of key genes that may signal premalignant changes.

"These same techniques can be used by the research and diagnostic testing communities to process very small tissue samples that are preserved by the standard method of formalin fixation,” said Mark G. Erlander, Ph.D., co-senior investigator and chief scientific officer of Arcturus. "Gene expression analysis can be performed on the most suitable analysis platform, from microarray technology to PCR.” The new techniques were developed by Arcturus and researchers at the University of Kansas Medical Center (Kansas City, KS, USA).




Related Links:
Arcturus

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.